A Novel Synthesis Method of Meriolin1
DOI:
https://doi.org/10.54097/ajst.v5i2.6292Keywords:
Meriolins, Synthesis, Anti-cancer, Kinase inhibitors, Marine organism.Abstract
Meriolins, a compound designed and synthesized by the similar structure of natural marine products Meridianins and Variolins, has been proved to be a new kinase inhibitor that can enhance protein kinase selectivity and cell death. It has stronger inhibitory activity, relative selectivity to kinases and antitumor effect. As the first compound in the Meriolins series, Meriolin1 has been studied the most. In this paper, the synthesis methods of Meriolin1 at home and abroad were summarized and analyzed. On this basis, a more economical and effective synthesis route was designed, that is, Meriolin1 was finally obtained from 7-azaindole through Friedel-crafts acylation, protection, aldol condensation and cyclization reaction. This route avoids the disadvantages of the existing routes and has the advantages of mild reaction conditions, simple operation and low cost. The structures of the compounds were confirmed by 1H NMR and 13C NMR.
Downloads
References
S.R. Walker, E.J. Carter, B.C. Huff, and J.C. Morris, “Variolins and related alkaloids”, Chemical Reviews, 2009, Vol. 109(7), p3080.
M.F. Pilar, M. Pedro, D. Santiago, “Synthetic studies towards the 2-aminopyrimidine alkaloids variolins and meridianins from marine origin”, Tetrahedron Letters, 2000, Vol. 41(24), p4777-4780．
M. Simone, E. Erba, G. Damia, F. Vikhanskaya and R. Riccardi, “Variolin B and its derivate deoxy-variolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity”, European Journal of Cancer, 2005, Vol. 41(15), p2366-2377.
M. Gompel, M. Leost, E. Joffe, L. Puricelli, L.H. Franco and J. Palermo, “Meridianins, a new family of protein kinase inhibitors isolated from the Ascidian Aplidium meridianum”, ChemInform, 2004, Vol. 35(7), p1703-1707.
S. Dan, W. Wenbin, W. Xinyue, L. Minyue, Y. Xue and H. Zhonghong, “Meriolin1 induces cell cycle arrest, apoptosis, autophagy and targeting the Akt/Mapks pathways in human neuroblastoma sh-sy5y cells”, The Journal of pharmacy and pharmacology, 2019, Vol. 72(4), p561-574.
J. Dumas, “Protein kinase inhibitors：emerging pharmacophores 1997-2000”, Expert Opinion on Therapeutic patents, 2001, Vol. 11(3), p405-429.
P. Traxler, P. Furet, “Strategies toward the design of novel and selective protein tyrosine kinase inhibitors”, Pharmacology therapeutics, 1999, Vol. 82(2), p195-206.
E.K. Bettay, O.M. Tirado, L.S. Marionneau, Y. Ferandin, O. Lozach and J.C. Morris, “Meriolins, a new class of cell death inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinases”, Cancer Research, 2007, Vol, 67(17), p8325-8334.
A.S. Karpov, E. Merkul, F. Rominger and T. Mueller, “Concise syntheses of meridianins by carbonylative alkynylation and a four-component pyrimidine synthesis”, ChemInform, 2006, Vol. 44(42), p6951-6956.
E. Merkul, E. Schaefe, and T.J.J. Mueller, “Rapid synthesis of bis(hetero)aryls by one-pot masuda borylation-suzuki coupling sequence and its application to concise total syntheses of meridianins a and g”, Organic & Biomolecular Chemistry, 2011, Vol. 9(9), p3139-3141.
W. Bernhard, B. Nicole, and B. Uwe, “Hydroboration and Suzuki-Miyaura coupling reactions with the electronically modulated variant of an Ynamine: the synthesis of (e)-β-Arylenamides”, Tetrahedron, 2000, Vol. 56(43), p8473.
A.K. Venkata, S. Feng, and F. Sulagna, “Cheminform abstract: boc groups as protectors and directors for ir-catalyzed c-h borylation of heterocycles”, ChemInform, 2010, Vol. 41(18), p9199-9201.
S.R. Walker, M.L. Czyz and J.C. Morris, “Concise syntheses of meridianins and meriolins using a catalytic domino amino-palladation reaction”, Organic Letters, 2014, Vol. 16(3), p708.
A. Fathi, A. Ahmed，and M. Sayed, “Synthesis of 1,4-Diaryl-piperazine-2,5-diones：New Behavior of N, N-Dimethylformamide Dimethyl Acetal (DMFDMA)”, Synthetic Communications, 2008, Vol. 38(3), p376-382.
T.M. Tarasiuk, A.V. Tatyana, and S.P. Kirill, “Reactions of 4,5-Dihydro-1,4-Benzothiazepin-3(2H)-one1,1-Dioxide and 1,5-Dihydro-4,1-Benzothiazepin-2(3H)-one 4,4-Dioxide Derivatives with Vilsmeier Reagent and DMFDMA”, Journal of Heterocyclic Chemistry, 2014, Vol. 51(3), p755-759.
Downloads
Published
Issue
Section
How to Cite
